These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33065484)

  • 1. Regulatory role of microRNAs in cancer through Hippo signaling pathway.
    Astamal RV; Maghoul A; Taefehshokr S; Bagheri T; Mikaeili E; Derakhshani A; Delashoub M; Taefehshokr N; Isazadeh A; Hajazimian S; Tran A; Baradaran B
    Pathol Res Pract; 2020 Dec; 216(12):153241. PubMed ID: 33065484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between Hippo signalling and miRNAs in tumour progression.
    Li N; Xie C; Lu N
    FEBS J; 2017 Apr; 284(7):1045-1055. PubMed ID: 27973704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAs and the Hippo pathway in cancer: Exploring the therapeutic potential (Review).
    Arora T; Kausar MA; Aboelnaga SM; Anwar S; Hussain MA; Sadaf S; Kaur S; Eisa AA; Shingatgeri VMM; Najm MZ; Aloliqi AA
    Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35699111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
    Chen M; Wang M; Xu S; Guo X; Jiang J
    Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor.
    Sebio A; Lenz HJ
    Clin Cancer Res; 2015 Nov; 21(22):5002-7. PubMed ID: 26384319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippo signaling promotes JNK-dependent cell migration.
    Ma X; Wang H; Ji J; Xu W; Sun Y; Li W; Zhang X; Chen J; Xue L
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1934-1939. PubMed ID: 28174264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective.
    Samji P; Rajendran MK; Warrier VP; Ganesh A; Devarajan K
    Cell Signal; 2021 Feb; 78():109858. PubMed ID: 33253912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness.
    Muñoz-Galván S; Felipe-Abrio B; Verdugo-Sivianes EM; Perez M; Jiménez-García MP; Suarez-Martinez E; Estevez-Garcia P; Carnero A
    Mol Cancer; 2020 Jan; 19(1):7. PubMed ID: 31926547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling.
    Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J
    Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the role of the Hippo pathway in cancer.
    Han Y
    J Transl Med; 2019 Apr; 17(1):116. PubMed ID: 30961610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hippo Pathway: Biology and Pathophysiology.
    Ma S; Meng Z; Chen R; Guan KL
    Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
    Wang C; Yin W; Liu H
    J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.
    Wang Y; Xu X; Maglic D; Dill MT; Mojumdar K; Ng PK; Jeong KJ; Tsang YH; Moreno D; Bhavana VH; Peng X; Ge Z; Chen H; Li J; Chen Z; Zhang H; Han L; Du D; Creighton CJ; Mills GB; ; Camargo F; Liang H
    Cell Rep; 2018 Oct; 25(5):1304-1317.e5. PubMed ID: 30380420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bantam microRNA is a target of the hippo tumor-suppressor pathway.
    Nolo R; Morrison CM; Tao C; Zhang X; Halder G
    Curr Biol; 2006 Oct; 16(19):1895-904. PubMed ID: 16949821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP and TAZ Take Center Stage in Cancer.
    Zhang K; Qi HX; Hu ZM; Chang YN; Shi ZM; Han XH; Han YW; Zhang RX; Zhang Z; Chen T; Hong W
    Biochemistry; 2015 Nov; 54(43):6555-66. PubMed ID: 26465056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the core Hippo signaling and biological macromolecules interactions in the biology of solid tumors.
    Mohammadi S; Arefnezhad R; Danaii S; Yousefi M
    Biofactors; 2020 Jul; 46(4):514-530. PubMed ID: 32445262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer.
    Mohajan S; Jaiswal PK; Vatanmakarian M; Yousefi H; Sankaralingam S; Alahari SK; Koul S; Koul HK
    Cancer Lett; 2021 Jun; 507():112-123. PubMed ID: 33737002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippo-YAP signaling pathway: A new paradigm for cancer therapy.
    Ma Y; Yang Y; Wang F; Wei Q; Qin H
    Int J Cancer; 2015 Nov; 137(10):2275-86. PubMed ID: 25042563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway.
    Zhu G; Wang Y; Mijiti M; Wang Z; Wu PF; Jiafu D
    Biochem Biophys Res Commun; 2015 Sep; 465(2):194-9. PubMed ID: 26241672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of Hippo pathway in gastric and other gastrointestinal cancers.
    Kang W; Cheng AS; Yu J; To KF
    World J Gastroenterol; 2016 Jan; 22(3):1279-88. PubMed ID: 26811664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.